Steadman R, Topley N. The virulence of Escherichia coli in Wromaru tract. Chapter 3. In : Brumfit
W, Jercmy MT, Hamilteon Miller Eds. Urinary tract infections. 1st ed..Chapman and Hall Publication,
London 1998 : 37-41.
2 Kaper JB, Nataro JP, Mobley HL, Pathogenic Escherichia coli. Nopt Rev Microbiol 2004; 2 : 123-
140.
1
Indian Journal of Basic & Applied Medical Research; September 2013: Issue-8, Vol.-2, P. 886-896
894
www.ijbamr.com
3 Walt B. The role of P. fimbriae for Escherichia coli establishment and mucosal inflammation in the
human urinary tract. Int J Antimicrob Agents 2002; 21 : 605-21.
4 Robser B. Immunology of Escherichia coli. K. antigen and its relation to urinary tract infection. J
Infect Dis 1973; 127 : 670-677.
5 Orskov I, Orskov F, Birch-Andersen A, Kanamori M, Svanborg EC. H. and fimbrial antigens in
Escherichia coli serotypes associated with pyelonephritis and cystitis, Scand J Infect Dis 1982; Suppl
33 : 18-25.
6 Bjorksten B, Kaijser B. Interaction of human serum and neutrophils with Escherichia coli strains :
differences between strains isolated from urine of patients with pyelonephritis or asymptomatic
bacteriuria. Infect Immun 1978; 2 : 308-311.
7 Seigfried L. Puzova H. Kmetova M, Kerestesova A. Killing of alpha-haemolytic and non-haemolytic
Escherichia coli strains in human serum and polymorphonuclear leucocytes. J Med Microbiol 1992;
37 : 3-7.
8 Hughes C, Hacker J. Roberts A, Goebel W. Hemolysin production as a virulence marker in
symptomatic and asymptomatic urinary tract infections caused by Escherichia coli. Infect Immn 1983;
39 : 546-551.
9 Cavalieri SJ. Bohach GA. Snyder IS. Escherichia coli alpha haemolysin : characteristics and probable
role in pathogenicity. Microbiol Rev 1984; 481, 326-343.
10 Quocken bush RL, Falkow S. Relationship between Colicin V activity and virulence in Escherichia
coli. Infect Immun 1979; 24 : 562-564.
11 Williams PH. Novel iron uptake system specified by Col. V plasmids : an important component in the
virulence of invasive strains of Escherichia coli. Infect Immun 1979; 26 : 925-932.
12 Jacobson SH, Hammerlind M. Lidefeldt kJ. Osterberg E, Tullus K, Brauner K. Incidence of
aerobactin-positive Escherichia coli strains in patients with symptomatic urinary tract infection. Eur J
Clin Microbiol Infect Dis 1988 : 7 : 630-634.
13 Moseley SL, Roberts PL, Stamm WE. Aerobactin other virulence factor genes among strains for
Escherichia coli causing urosepsis; association with patient characteristics. Infect Immun 1988; 56 :
405-412.
14 Caprioli A, FAlbo V. Ruggeri FM et al. Cytotoxic necrotizing factor production by haemolytic strains
Indian Journal of Basic & Applied Medical Research; September 2013: Issue-8, Vol.-2, P. 886-896
895
www.ijbamr.com
to Escherichia coli causing extraintestinal infections. J Clin Microbiol 1987; 25 : 46-149.
15 Blanco Alonso MP, Gonzalez EA, Balanco M, Garabal JI. Virlence factors of bacteraemic Escherichia
coli with particular reference to production of cytotoxic necrotizing factor (CNF) by P-fimbriate
strains. J Med Microbiol 1990; 31 : 175-183.
16 Gonzales EA, Banco J, Baloda SB, Wadstrom T. Relative cell surface hydrophobicity of Escherichia
coli strains with various recognized fimbrial antigens and without recognized fimbriae. Zentralbl
Bakteriol Mikrobiol Hya A. 1988; 269 : 218-236.
17 Rebecca N, Elizabeth M. Some virulence characteristics of uropathogenic Escherichia coli in different
patient groups. Indian J Med Res 2005, 122 : 143-147.
18 Schaeffer JA. Infection of the urinary tract . In: Walsh, Retike, Vaghen Wein. Cambell’s Urology, 7th
edition Philadelphia 1990;1: 534-611.
19 Ellen Jo Barren, Sydney M, Finegold. Diagnostic microbiology.In Bailey and Scott. 8th edition.
Mosby Public Philadelphia Toronto, Baltimore 1990: 259-260.
20 National Committee for laboratory standards .Performance standards for antimicrobial disc
susceptibility tests:approved standard (M2-A8).Wayne,PA:NCCLS,2003.
21 Smith HW. The haemolysin of Escherichia coli. J Pathol Bacteriol 1963; 85 : 197-211.
22 Siegfried L, Marta Kimetera, Hana Puzova. Virulence associated factors in Escherichia coli strains
isolated from children with urinary tract infections. J Med Microbiol 1994; 41 : 127-152.
23 Johnson JR. Virulence factors in Escherichia coli urinary tract infections. Clin Microbiol Rev. 1991;
4: 81-128.
24 Rozgonyi F, Szitha F, Ljungh KR, Baloda A. Improvement of the salt aggregation test to study
bacterial cell surface hydrophobicity. FEMS Microbiol; Lett 1985; 30 : 131-138
25 Brookes HJL, Benseman BA and Peck J. Correlation between uropathogenic properties of
Escherichia coli from urinary tract infections and the antibody coated bacteria test and comparison
with faecal strains. J Hyg 1981; 87 : 53-61.
26 Minshew BH, Jorgensen J, Swanstrun M, Grootes-Reuvecamp. Some characteristics of Escherichia
coli strains isolated from extraintestinal infections of humans. J Infect Dis 1978; 137 : 648-654.
27 Green PC, Thomas VL. Haemagglutination of human type O erythrocytes. Haemolysin production
Indian Journal of Basic & Applied Medical Research; September 2013: Issue-8, Vol.-2, P. 886-896
896
www.ijbamr.com
and serogrouping of Escherichia coli isolates from patients with acute pyelonephritis cystitis and
asymptomatic bacteriuria Infect Immun 1981; 31 (1) : 305-309
28 Taylor PW. Immunochemical investigations on lipopolysaccharides and acidic polysaccharides from
serum sensitive and serum resistant strains of Escherichia coli isolated from urinary tract infections. J
Med Microbiol Rev 1983; 47 : 46-83
29 Raksha R, Srinivasa H, Macaden RS. Occurrence and characterization of uropathogenic Escherichia
coli in urinary tract infections. Ind J Med Microbiol 2003; 21 : 102-107
Bhalla and Agarwal P. Urinary Escherichia coli prevalent serotypes antimicrobial
susceptibility andvirulence factors. Indian J Med Microbiol 1989; 7 : 88
31 Johnson JR, Robberts PL, Stamm WE. P. fimbriae and other virulence factors in Escherichia coli
urosepsis : Association with patients characteristics. J Infect Dis 1987; 156 : 225-229
Thank you for copying data from http://www.arastirmax.com